Network Bio Launches With $50 Million Financing And $30+ Million AI Partnership To Build Disease-Specific Models
By Amit Chowdhry ● Aug 20, 2026
Network Bio has launched with $50 million in financing to build disease-specific artificial intelligence models trained on large-scale human tissue, blood, molecular and clinical datasets, as the biotechnology company seeks to apply AI to diagnostics, biomarker discovery and drug development. Investors include Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund, JSL Health Capital and other life sciences and AI-focused funds.